Immunogenicity of a subunit vaccine against Bacillus anthracis

Vaccine

Volumn 25, Issue 16 SPEC. ISS., 2007, Pages 3111-3114

  Chichester, Jessica A ^a   Musiychuk, Konstantin ^a   de la Rosa, Patricia ^a   Horsey, April ^a   Stevenson, Natalie ^a   Ugulava, Natalia ^a   Rabindran, Shailaja ^a   Palmer, Gene A ^a   Mett, Vadim ^a   Yusibov, Vidadi ^a  

^a Fraunhofer USA Inc   (United States)

Author keywords

Anthrax; Plant expression; Subunit vaccine

Indexed keywords

IMMUNOGLOBULIN G1; LICHENASE LETHAL FACTOR; LICHENASE PROTECTIVE ANTIGEN; PLANT ANTIGEN; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBODY TITER; ARTICLE; BACILLUS ANTHRACIS; BIOENGINEERING; CELL PROTECTION; CLOSTRIDIUM THERMOCELLUM; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME STABILITY; EXPERIMENTAL STUDY; FEMALE; IMMUNOGENICITY; IN VITRO STUDY; LETHAL GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; THERMOSTABILITY; TOBACCO;

EID: 33947574275     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.068     Document Type: Article

References (13)

1. Ascenzi P., Visca P., Ippolito G., Spallarossa A., Bolognesi M., and Montecucco C. Anthrax toxin: a tripartite lethal combination. FEBS Lett 531 3 (2002) 384-388
2. Ivins B.E., and Welkos S.L. Recent advances in the development of an improved, human anthrax vaccine. Eur J Epidemiol 4 1 (1988) 12-19
3. Flick-Smith H.C., Walker N.J., Gibson P., Bullifent H., Hayward S., Miller J., et al. A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection. Infect Immun 70 3 (2002) 1653-1656
4. Pezard C., Weber M., Sirard J.C., Berche P., and Mock M. Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect Immun 63 4 (1995) 1369-1372
5. Brossier F., Levy M., Landier A., Lafaye P., and Mock M. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies. Infect Immun 72 11 (2004) 6313-6317
6. Price B.M., Liner A.L., Park S., Leppla S.H., Mateczun A., and Galloway D.R. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect Immun 69 7 (2001) 4509-4515
7. Musiychuk K., Stephenson N., Bi H., Farrance C.E., Orozovic G., Brodelius M., et al. A launch vector for the production of vaccine antigens in plants. Influenza 1 (2007) 19-25
8. Shivprasad S., Pogue G.P., Lewandowski D.J., Hidalgo J., Donson J., Grill L.K., et al. Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors. Virology 255 2 (1999) 312-323
9. Hull A.K., Criscuolo C.J., Mett V., Groen H., Steeman W., Westra H., et al. Human-derived, plant-produced monoclonal antibody for the treatment of anthrax. Vaccine 23 17-18 (2005) 2082-2086
10. Lim N.K., Kim J.H., Oh M.S., Lee S., Kim S.Y., Kim K.S., et al. An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin. Infect Immun 73 10 (2005) 6547-6551
11. Gu M.L., Leppla S.H., and Klinman D.M. Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine 17 4 (1999) 340-344
12. Weiss S., Kobiler D., Levy H., Marcus H., Pass A., Rothschild N., et al. Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits. Infect Immun 74 1 (2006) 394-398
13. Koya V., Moayeri M., Leppla S.H., and Daniell H. Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect Immun 73 12 (2005) 8266-8274